About

Clal Biotechnology Industries (TASE: CBI) is Israels largest life sciences investment company. CBI is focused on identifying and supporting promising innovative ventures, developing proprietary solutions, addressing unmet medical needs with multibillion dollar market potential. With offices in Tel-Aviv and Boston, we provide our companies access to the global biotechnology industry.

Key facts

Website: cbi.co.il
Type: Investment Firm
Headquarters: Israel
Portfolio companies: 2
Stages: Series B
Series G
Cheque size: $16M to $71M
Sector focus: Healthcare
Diagnostics
Blood
Life Sciences

Recent investments

Recent funding rounds Clal Bio took part in
Date	Company	Round	Amount
26 Jul 2020	Sight Diagnostics	Series D	$71M
30 Nov 2018	Sight Diagnostics	Series C	$28M
19 Jun 2017	Gamida Cell	Series G	$40M
31 Jul 2016	Sight Diagnostics	Series B	$16M

Add first review

Frequently asked

What companies has Clal Bio invested in?

Clal Bio has invested in Sight Diagnostics, Gamida Cell.